Concepedia

Author

Klaus Pietzner

Charité - Universitätsmedizin BerlinORCID

Also Known As

K Pietzner, K. Pietzner, KLAUS PIETZNER, Klaus Pietzner, Klaus, Pascal, Kristine Madsen, P Klaus, P. Klaus, Pascal Klaus, Pietzner Klaus

199

Publications

1.4K

Citations

22

H-Index

28

Concepts

All Affiliations

Charité - Universitätsmedizin BerlinUniversität HamburgHumboldt-Universität zu BerlinUniversity Medical Center Hamburg-EppendorfLudwig-Maximilians-Universität München
KP

About

Klaus Pietzner is an author at Charité - Universitätsmedizin Berlin specializing in oncology, medicine, and obstetrics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

13

14

471

2

Obstetrics

11

11

430

3

Pathology

7

7

131

4

Health Sciences

1

1

14

5

Neurology

1

1

40

Klaus Pietzner

×

31

Publications

910

Citations

18

H-Index

YearCitations

Sorafenib plus topotecan versus placebo plus topotecan for platinum-resistant ovarian cancer (TRIAS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

Radoslav Chekerov, Felix Hilpert, Sven� Mahner,

The Lancet Oncology

2018

108

Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial

Nicoletta Colombo, Elena Biagioli, Kenichi Harano,

The Lancet Oncology

2024

89

Magnetic Resonance Imaging–Guided Balloon Angioplasty of Coarctation of the Aorta

Julia Krueger, Peter Ewert, Sevim Yilmaz,

Circulation

2006

79

Role of histological type on surgical outcome and survival following radical primary tumour debulking of epithelial ovarian, fallopian tube and peritoneal cancers

Elena Ioana Braicu, Jalid Sehouli, Ralf P. Richter,

British Journal of Cancer

2011

71

Prognostic role of platinum sensitivity in patients with brain metastases from ovarian cancer: results of a German multicenter study

Jalid Sehouli, Klaus Pietzner, Philipp Harter,

Annals of Oncology

2010

50

Brain metastases from epithelial ovarian cancer: overview and optimal management.

Klaus Pietzner, Guelten Oskay-Oezcelik, K. El Khalfaoui,

PubMed

2009

40

Overexpression of the epithelial cell adhesion molecule is associated with a more favorable prognosis and response to platinum-based chemotherapy in ovarian cancer

Hannah Woopen, Klaus Pietzner, Rolf Richter,

Journal of Gynecologic Oncology

2014

38

Quaternary cytoreductive surgery in ovarian cancer: does surgical effort still matter?

Christina Fotopoulou, Konstantinos Savvatis, Philipp Kosian,

British Journal of Cancer

2013

31

Implementation of Enhanced Recovery After Surgery (ERAS) Pathways in Gynecologic Oncology. A NOGGO-AGO* survey of 144 Gynecological Departments in Germany.

Mustafa Zelal Muallem, Desislava Dimitrova, Klaus Pietzner,

PubMed

2016

29

HE4 Expression in Plasma Correlates with Surgical Outcome and Overall Survival in Patients with First Ovarian Cancer Relapse

Elena Ioana Braicu, Radoslav Chekerov, Rolf Richter,

Annals of Surgical Oncology

2013

28

Page 1